← Back to Search

Destek V4 Virtual Reality Headset for Oncologic Complications

N/A
Waitlist Available
Led By June Y. Hou, MD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-4 months
Awards & highlights

Study Summary

This trial will explore if virtual reality can help reduce adverse symptoms for women with gynecologic cancer during chemotherapy. Patients will serve as their own control and the study will last 3 months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Symptom Survey A
Symptom Survey B

Trial Design

1Treatment groups
Experimental Treatment
Group I: Virtual reality armExperimental Treatment1 Intervention
Participants will be asked to use virtual reality during their infusion for a duration of at least 10 minutes.

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,432 Previous Clinical Trials
2,460,973 Total Patients Enrolled
June Y. Hou, MDPrincipal InvestigatorColumbia University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Virtual Reality for Chemotherapy Patients
June Hou 2022. "Virtual Reality for Chemotherapy Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04723108.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top